Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Carlos Torre Alonso

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Reumatologia Clinica|July 29, 2011
[Not Available]Juan Carlos Torre Alonso
Reumatologia Clinica|July 29, 2011
[Use and application in clinical practice of the CASPAR criteria]Juan Carlos Torre Alonso
Clinical Rheumatology|April 21, 2025
The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of lifeIgnacio Braña, Marta Loredo, Juan Carlos Torre-Alonso, et al.
Patient Preference and Adherence|May 22, 2018
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literatureJuan Carlos Torre-Alonso, Rubén Queiro, Marta Comellas, et al.
The Journal of Rheumatology|May 23, 2002
MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritisSegundo González, Jesús Martínez-Borra, Antonio López-Vázquez, et al.
Reumatologia Clinica|May 10, 2022
Expert recommendations for the use of apremilast in psoriatic arthritisJuan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, et al.
Reumatologia Clinica|June 6, 2013
Comparison of 2 referral strategies for the diagnosis of axial spondyloarthritis in Spain. The RADAR studyXavier Juanola, José Luis Fernández-Sueiro, Juan Carlos Torre-Alonso, et al.
Reumatologia Clinica|November 8, 2017
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritisJuan Carlos Torre Alonso, Petra Díaz Del Campo Fontecha, Raquel Almodóvar, et al.
Human Immunology|July 18, 2002
High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern SpainSegundo Gonzalez, Sonia Garcia-Fernandez, Jesus Martinez-Borra, et al.
The Journal of Rheumatology|March 3, 2011
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitisNuria Montala, Xavier Juanola, Eduardo Collantes, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Reumatologia Clinica|July 29, 2011
[Not Available]Juan Carlos Torre Alonso
Reumatologia Clinica|July 29, 2011
[Use and application in clinical practice of the CASPAR criteria]Juan Carlos Torre Alonso
Clinical Rheumatology|April 21, 2025
The VITACORA- 19 and PsAID questionnaires are equally valid for assessing the impact of psoriatic arthritis on patients' quality of lifeIgnacio Braña, Marta Loredo, Juan Carlos Torre-Alonso, et al.
Patient Preference and Adherence|May 22, 2018
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literatureJuan Carlos Torre-Alonso, Rubén Queiro, Marta Comellas, et al.
The Journal of Rheumatology|May 23, 2002
MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritisSegundo González, Jesús Martínez-Borra, Antonio López-Vázquez, et al.
Reumatologia Clinica|May 10, 2022
Expert recommendations for the use of apremilast in psoriatic arthritisJuan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, et al.
Reumatologia Clinica|June 6, 2013
Comparison of 2 referral strategies for the diagnosis of axial spondyloarthritis in Spain. The RADAR studyXavier Juanola, José Luis Fernández-Sueiro, Juan Carlos Torre-Alonso, et al.
Reumatologia Clinica|November 8, 2017
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritisJuan Carlos Torre Alonso, Petra Díaz Del Campo Fontecha, Raquel Almodóvar, et al.
Human Immunology|July 18, 2002
High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern SpainSegundo Gonzalez, Sonia Garcia-Fernandez, Jesus Martinez-Borra, et al.
The Journal of Rheumatology|March 3, 2011
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitisNuria Montala, Xavier Juanola, Eduardo Collantes, et al.
Pageof 3